Default company panoramic image
3a01fc70 80b8 42ac a9ac 32ad70634e68

Nutraceutical Research Innovations, LLC

We combine cutting edge science, chemistry, and technology in the manufacturing, distribution, and marketing of new health and beauty brands

Company Summary

Nutraceutical Research Innovations, LLC specializes in the development of nutraceutical and cosmeceutical products for commercialization specifically focusing on over the counter, health and beauty consumer goods. The company utilizes expert direct response marketing technology and strategy in entering into markets quickly and efficiently. The company's first brand is Zenagen™ developed to biochemically target hair loss in only 5 minutes of use.


  • Default avatar
    Jared Reynolds
    CEO, Founder

    Mr. Reynolds is a leading biochemistry and formulation expert in the field of nutraceutical and cosmeceutical development and commercialization.
    Background includes advancements in cosmetic extraction and formulation through utilizing R&D with focus on utilizing effective nutraceutical based products and brands. Mr. Reynolds holds a BS in Biochemistry Molecular Biology and Attended NSU Medical School before starting NRI, LLC.

  • Default avatar
    Marc Osgood
    Partner Chief Marketing Officer

    Marc Osgood has over 20 years of marketing and brand building experience for some of the largest and most respected brands in the country. He ran one of the most successful campaigns ever sold through direct response television, Billy Blanks Taebo™ achieving an estimated $150 million dollars in direct response sales alone before entering the retail channels. Marc most recently was the Director of the Direct Response Division at Oreck Corporation.

  • Default avatar
    Stephen Watson
    Chief Financial Officer

    Steve Watson and has over 25 years of accounting and finance experience in consumer package goods and international distribution operations. As Gibson Guitars corporate controller responsibilities included oversight of financial statements, budgeting and analysis, consolidation of divisional information and management. Steve assisted in the acquisition of Baldwin Piano. Steve holds a B.S. in Accounting and a M.B.A. from Belmont University.

  • Default avatar
    Eric Elmquist, PhD
    Chief Science Associate

    Dr. Elmquist, PhD is an expert of chemistry and biochemical processes and research focused on on DNA and RNA damage in relation to chronic inflammation and cancer. Most recently Dr. Elmquist was a Science Researcher at BioMimetic Therapeutics.
    Dr. Elquist holds a PhD in Chemistry from Vanderbilt University and Postdoctoral Fellowship at MIT.


  • Default avatar
    Daniel Gianotti, Esq.
    Default avatar
    Stephen Watson, MBA

Previous Investors

  • Default avatar
    Minority Private Investors